Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2180331821', 'doi': 'https://doi.org/10.1016/s0960-894x(02)00456-0', 'title': 'l-Cysteine based N-type calcium channel blockers: structure–activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models', 'display_name': 'l-Cysteine based N-type calcium channel blockers: structure–activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models', 'publication_year': 2002, 'publication_date': '2002-09-01', 'ids': {'openalex': 'https://openalex.org/W2180331821', 'doi': 'https://doi.org/10.1016/s0960-894x(02)00456-0', 'mag': '2180331821', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12161113'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0960-894x(02)00456-0', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30970080', 'display_name': 'Bioorganic & Medicinal Chemistry Letters', 'issn_l': '0960-894X', 'issn': ['0960-894X', '1464-3405'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5073892110', 'display_name': 'Takuya Seko', 'orcid': 'https://orcid.org/0000-0002-1245-6414'}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Takuya Seko', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035928006', 'display_name': 'Masashi Kato', 'orcid': 'https://orcid.org/0000-0002-3515-5526'}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masashi Kato', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018915821', 'display_name': 'Hiroshi Kohno', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hiroshi Kohno', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059950251', 'display_name': 'Shota Ono', 'orcid': 'https://orcid.org/0000-0001-6676-1329'}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shizuka Ono', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039091051', 'display_name': 'Kazuya Hashimura', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kazuya Hashimura', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041917413', 'display_name': 'Yoshifumi Takenobu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yoshifumi Takenobu', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064165211', 'display_name': 'Hideyuki Takimizu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hideyuki Takimizu', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053361506', 'display_name': 'Katsuhiko Nakai', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Katsuhiko Nakai', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075290556', 'display_name': 'Hitoshi Maegawa', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hitoshi Maegawa', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060507180', 'display_name': 'Nobuo Katsube', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Nobuo Katsube', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5051760258', 'display_name': 'Masaaki Toda', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masaaki Toda', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5073892110'], 'corresponding_institution_ids': ['https://openalex.org/I4210112155'], 'apc_list': {'value': 3660, 'currency': 'USD', 'value_usd': 3660, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 1.32, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 23, 'citation_normalized_percentile': {'value': 0.777934, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '12', 'issue': '17', 'first_page': '2267', 'last_page': '2269'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10196', 'display_name': 'Mechanisms and Management of Neuropathic Pain', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10196', 'display_name': 'Mechanisms and Management of Neuropathic Pain', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10493', 'display_name': 'Molecular Mechanisms of Ion Channels Regulation', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13047', 'display_name': 'Role of Sigma Receptors in Cellular Signaling', 'score': 0.9981, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/n-type-calcium-channel', 'display_name': 'N-type calcium channel', 'score': 0.7556319}, {'id': 'https://openalex.org/keywords/moiety', 'display_name': 'Moiety', 'score': 0.71958363}, {'id': 'https://openalex.org/keywords/l-type-calcium-channel', 'display_name': 'L-type calcium channel', 'score': 0.6471554}, {'id': 'https://openalex.org/keywords/calcium-signaling', 'display_name': 'Calcium Signaling', 'score': 0.568059}, {'id': 'https://openalex.org/keywords/calcium-channels', 'display_name': 'Calcium Channels', 'score': 0.562726}, {'id': 'https://openalex.org/keywords/pain-modulation', 'display_name': 'Pain Modulation', 'score': 0.503595}, {'id': 'https://openalex.org/keywords/channel-blocker', 'display_name': 'Channel blocker', 'score': 0.4206233}], 'concepts': [{'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.8925674}, {'id': 'https://openalex.org/C85520022', 'wikidata': 'https://www.wikidata.org/wiki/Q15322916', 'display_name': 'Calcium channel', 'level': 3, 'score': 0.7623156}, {'id': 'https://openalex.org/C92645518', 'wikidata': 'https://www.wikidata.org/wiki/Q26916851', 'display_name': 'N-type calcium channel', 'level': 5, 'score': 0.7556319}, {'id': 'https://openalex.org/C2780820201', 'wikidata': 'https://www.wikidata.org/wiki/Q173235', 'display_name': 'Analgesic', 'level': 2, 'score': 0.74246967}, {'id': 'https://openalex.org/C2776568683', 'wikidata': 'https://www.wikidata.org/wiki/Q23005640', 'display_name': 'Moiety', 'level': 2, 'score': 0.71958363}, {'id': 'https://openalex.org/C117499352', 'wikidata': 'https://www.wikidata.org/wiki/Q2600696', 'display_name': 'L-type calcium channel', 'level': 4, 'score': 0.6471554}, {'id': 'https://openalex.org/C2779201268', 'wikidata': 'https://www.wikidata.org/wiki/Q186474', 'display_name': 'Cysteine', 'level': 3, 'score': 0.6084989}, {'id': 'https://openalex.org/C18699975', 'wikidata': 'https://www.wikidata.org/wiki/Q14905735', 'display_name': 'Voltage-dependent calcium channel', 'level': 3, 'score': 0.53304094}, {'id': 'https://openalex.org/C519063684', 'wikidata': 'https://www.wikidata.org/wiki/Q706', 'display_name': 'Calcium', 'level': 2, 'score': 0.52900964}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.52057797}, {'id': 'https://openalex.org/C30979828', 'wikidata': 'https://www.wikidata.org/wiki/Q2487620', 'display_name': 'T-type calcium channel', 'level': 4, 'score': 0.46778616}, {'id': 'https://openalex.org/C116073593', 'wikidata': 'https://www.wikidata.org/wiki/Q864491', 'display_name': 'Biological activity', 'level': 3, 'score': 0.4339058}, {'id': 'https://openalex.org/C2777107010', 'wikidata': 'https://www.wikidata.org/wiki/Q2798704', 'display_name': 'Neuropathic pain', 'level': 2, 'score': 0.42706275}, {'id': 'https://openalex.org/C153461711', 'wikidata': 'https://www.wikidata.org/wiki/Q5072487', 'display_name': 'Channel blocker', 'level': 3, 'score': 0.4206233}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.40216923}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.24016824}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.2227568}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.08527124}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.081869096}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D002121', 'descriptor_name': 'Calcium Channel Blockers', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D020864', 'descriptor_name': 'Calcium Channels, N-Type', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D003545', 'descriptor_name': 'Cysteine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D010146', 'descriptor_name': 'Pain', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000700', 'descriptor_name': 'Analgesics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000700', 'descriptor_name': 'Analgesics', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000700', 'descriptor_name': 'Analgesics', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000700', 'descriptor_name': 'Analgesics', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002121', 'descriptor_name': 'Calcium Channel Blockers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002121', 'descriptor_name': 'Calcium Channel Blockers', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D002121', 'descriptor_name': 'Calcium Channel Blockers', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D020864', 'descriptor_name': 'Calcium Channels, N-Type', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003251', 'descriptor_name': 'Constriction, Pathologic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003545', 'descriptor_name': 'Cysteine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004353', 'descriptor_name': 'Drug Evaluation, Preclinical', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D057927', 'descriptor_name': 'Hydrophobic and Hydrophilic Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020128', 'descriptor_name': 'Inhibitory Concentration 50', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010146', 'descriptor_name': 'Pain', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010146', 'descriptor_name': 'Pain', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013329', 'descriptor_name': 'Structure-Activity Relationship', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013810', 'descriptor_name': 'Therapeutic Equivalency', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0960-894x(02)00456-0', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30970080', 'display_name': 'Bioorganic & Medicinal Chemistry Letters', 'issn_l': '0960-894X', 'issn': ['0960-894X', '1464-3405'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12161113', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.65, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 14, 'referenced_works': ['https://openalex.org/W1997843197', 'https://openalex.org/W1998717404', 'https://openalex.org/W2001933690', 'https://openalex.org/W2038935287', 'https://openalex.org/W2058020736', 'https://openalex.org/W2058364076', 'https://openalex.org/W2061814302', 'https://openalex.org/W2063413377', 'https://openalex.org/W2066352663', 'https://openalex.org/W2076437075', 'https://openalex.org/W2091257267', 'https://openalex.org/W2118309627', 'https://openalex.org/W2135820816', 'https://openalex.org/W2180452219'], 'related_works': ['https://openalex.org/W4286824615', 'https://openalex.org/W4210656107', 'https://openalex.org/W33108975', 'https://openalex.org/W3090426893', 'https://openalex.org/W3004827299', 'https://openalex.org/W2391138859', 'https://openalex.org/W2333214033', 'https://openalex.org/W2152655666', 'https://openalex.org/W2143665938', 'https://openalex.org/W2057480677'], 'abstract_inverted_index': {'This': [0], 'study': [1], 'was': [2, 19, 40, 65], 'performed': [3], 'to': [4, 42], 'determine': [5], 'the': [6, 22, 83, 90, 101], 'structure-activity': [7], 'relationships': [8], '(SAR)': [9], 'of': [10, 26, 33, 54, 100, 105], 'L-cysteine': [11, 27], 'based': [12], 'N-type': [13, 48, 69], 'calcium': [14, 49, 58, 70], 'channel': [15, 50], 'blockers.': [16], 'Basic': [17], 'nitrogen': [18], 'introduced': [20], 'into': [21], 'C-terminal': [23], 'lipophilic': [24], 'moiety': [25], 'with': [28, 52], 'a': [29, 44], 'view': [30], 'toward': [31], 'improvement': [32], 'its': [34], 'physicochemical': [35], 'properties.': [36], 'L-Cysteine': [37], 'derivative': [38], '9': [39, 76], 'found': [41], 'be': [43], 'potent': [45], 'and': [46, 64, 89], 'selective': [47, 67], 'blocker': [51], 'IC(50)': [53], '0.33': [55], 'microM': [56], 'in': [57, 82], 'influx': [59], 'assay': [60], 'using': [61], 'IMR-32': [62], 'cells': [63], '15-fold': [66], 'for': [68], 'channels': [71], 'over': [72], 'L-type': [73], 'channels.': [74], 'Compound': [75], 'showed': [77], 'improved': [78], 'oral': [79], 'analgesic': [80], 'efficacy': [81], 'rat': [84, 91], 'formalin': [85], 'induced': [86], 'pain': [87], 'model': [88], 'chronic': [92, 106], 'constriction': [93], 'injury': [94], '(CCI)': [95], 'model,': [96], 'which': [97], 'is': [98], 'one': [99], 'most': [102], 'reliable': [103], 'models': [104], 'neuropathic': [107], 'pain,': [108], 'without': [109], 'any': [110], 'significant': [111], 'effect': [112], 'on': [113], 'blood': [114], 'pressure': [115], 'or': [116], 'neurological': [117], 'behavior.': [118]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2180331821', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-09-19T21:48:16.402022', 'created_date': '2016-06-24'}